Results 71 to 80 of about 5,464 (192)

Optimising coronary reperfusion in acute myocardial infarction: the role of primary angioplasty

, 2007
PhDThrombolysis remains the predominant reperfusion strategy for ST segment elevation myocardial infarction (STEMI) in the United Kingdom. Although primary angioplasty may offer superior outcomes, the logistics of delivering this therapy in the UK ...
Smith, Elliot J
core  

Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction - The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial

, 2003
Background-Trials of platelet glycoprotein IIb/IIIa inhibitors as adjuncts to primary percutaneous coronary intervention for acute myocardial infarction (MI) have shown improved early clinical and angiographic outcomes with treatment. However, variations
Fahy, M, Cox, DA, Turco, Mark, Mehran, R, Kandzari, David E, Stone, GW, Cox, David A, Stuckey, T, Kandzari, DE, Lansky, Alexandra J, Turco, M, Garcia, Eulogio, Grines, CL, Lansky, AJ, Garcia, E, Tcheng, JE, Griffin, JJ, Tcheng, James E, Effron, Mark B, Stuckey, Thomas, Grines, Cindy L, Fahy, Martin, Effron, MB, Stone, Gregg W, Griffin, John J, Guagliumi, Giulio, Guagliumi, G, Mehran, Roxana   +27 more
core   +1 more source

Investigation of interaction of human platelet membrane components with anticoagulant drugs Abciximab and Eptifibatide

Folia Histochemica et Cytobiologica, 2010
Abciximab (Abci) and eptifibatide (Epti) are antiaggregate drugs which may reduce thrombotic complications inacute coronary syndromes. The aim of this work was the investigation of the interaction between the phospholipid-GPIIb/IIIa glycoprotein complex ...
Ewa Gorodkiewicz, Anna Sankiewicz, Zbigniew A. Figaszewski   +2 more
doaj  

High bolus tirofiban vs abciximab in acute STEMI patients undergoing primary PCI - The tamip study

Heart Views, 2012
Background: Primary percutaneous coronary intervention (PCI) has been shown to be an effective therapy for patients with acute myocardial infarction (MI). Glycoprotein (GP) IIb/IIIa receptor blockers reduce thrombotic complications in patients undergoing
Mohammed A Balghith
doaj   +1 more source

An Additional Mechanism of Action of Abciximab: Dispersal of Newly Formed Platelet Aggregates

, 2002
SummaryThe ability of abciximab to prevent fibrinogen binding to activated platelets indicates it may also promote dissolution of platelet-rich thrombi. The present study examined the capacity of abciximab to reverse platelet aggregation in vitro.
Andrew Frelinger, Joseph Jakubowski, Robert Jordan, Mary Mascelli, Peter Marchese, Stanley Marciniak, Mark Furman, Alan Michelson   +7 more
core   +1 more source

Intracranial bleeding mimicking an extensive acute myocardial infarction with reversible apical ballooning and systolic left ventricular dysfunction. A case report

Monaldi Archives for Chest Disease, 2016
A novel syndrome with transient asynergy of the apical segments of the left ventricle, also known as tako-tsubo cardiomyopathy, has been recently described and presents characteristics and effects similar to acute myocardial infarction.
Antonio D’Aloia, Enrico Vizzardi, Pompilio Faggiano, Claudia Fiorina, Livio Dei Cas   +4 more
doaj   +1 more source

Terapia con anticuerpos monoclonales en Cardiología y Medicina Interna

Revista Colombiana de Cardiología, 2016
La terapia biológica basada en anticuerpos monoclonales, constituyen una nueva herramienta terapéutica, que de la mano del desarrollo de la biología molecular permiten intervenir puntos claves en la etiopatogenia de la enfermedad, permitiendo una terapia
Christian David Adams-Sánchez, Gabriel Jaime Tobón-García   +1 more
doaj   +1 more source

Abciximab in the treatment of coronary artery disease

, 2013
Antiplatelet therapy constitutes a cornerstone in the strategies aimed at the effective management of acute coronary syndrome. Abciximab is the oldest and most commonly used intravenous antiplatelet agent in this context, in particular when an invasive ...
Maxwell, Ryan, Murdoch, Dale, Jayasinghe, Rohan   +2 more
core   +3 more sources

On the use of abciximab in percutaneous coronary intervention

, 2011
Introduction: The present thesis ´On the use of abciximab in percutaneous coronary intervention´ is based on 6 papers concerning the glycoprotein IIb/IIIa inhibitor, abciximab. The thesis is divided into 2 sections.
Iversen, Allan
core  

Clinical impact of abciximab on long-term outcome after complex coronary angioplasty

, 2003
Glycoprotein IIb/IIIa receptor antagonists, such as abciximab, are used to reduce major adverse cardiac events (MACES) in patients undergoing percutaneous transluminal coronary angioplasty.
Versteeg, DIK, Tio, RA, Wijpkema, JS, Van Boven, AJ, Jessurun, GAJ, Hautvast, RWM   +5 more
core   +1 more source